How does metabolism affect cell death in cancer?
In cancer research, identifying a specificity of tumor cells compared with 'normal' proliferating cells for targeted therapy is often considered the Holy Grail for researchers and clinicians. Although diverse in origin, most cancer cells share characteristics including the ability to escape cell death mechanisms and the utilization of different methods of energy production. In the current paradigm, aerobic glycolysis is considered the central metabolic characteristic of cancer cells (Warburg effect). However, recent data indicate that cancer cells also show significant changes in other metabolic pathways. Indeed, it was recently suggested that Kreb's cycle, pentose phosphate pathway intermediates, and essential and nonessential amino acids have key roles. Renewed interest in the fact that cancer cells have to reprogram their metabolism in order to proliferate or resist treatment must take into consideration the ability of tumor cells to adapt their metabolism to the local microenvironment (low oxygen, low nutrients). This variety of metabolic sources might be either a strength, resulting in infinite possibilities for adaptation and increased ability to resist chemotherapy-induced death, or a weakness that could be targeted to kill cancer cells. Here, we discuss recent insights showing how energetic metabolism may regulate cell death and how this might be relevant for cancer treatment.
Inserm, U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), équipe 'contrôle métabolique des morts cellulaires', Nice, France.|Faculté de Médecine, Université de Nice-Sophia-Antipolis, Nice, France.
Elodie
E
Villa
Inserm, U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), équipe 'contrôle métabolique des morts cellulaires', Nice, France.|Faculté de Médecine, Université de Nice-Sophia-Antipolis, Nice, France.|Département d'Anesthésie Réanimation, Centre Hospitalier Universitaire de Nice, Nice, France.
Jean-Ehrland
JE
Ricci
D000596:Amino Acids / Q000378:metabolism; D000818:Animals; D016923:Cell Death / Q000502:physiology*; D049109:Cell Proliferation / Q000502:physiology; D006801:Humans; D053858:Metabolic Networks and Pathways; D008954:Models, Biological; D009369:Neoplasms / Q000378:metabolism* / Q000473:pathology*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism; D059016:Tumor Microenvironment / Q000502:physiology
D000596:Amino Acids; D019253:Proto-Oncogene Proteins c-bcl-2
Bcl-2 family; Warburg; cancer; cell death; chemotherapy; glucose; glutamine; metabolism; nonapoptotic death; oncogene